The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biologic Injectors-Global Market Insights and Sales Trends 2024
Synopsis
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
The global Biologic Injectors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Injectors in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgical Centers and Others, are propelling Biologic Injectors market. Disposable Biologic Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reusable Biologic Injectors segment is estimated at % CAGR for the next seven-year period.
Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Injectors covered in this report include BD, Johnson & Johnson, Roche, Schott, Bayer, Nipro, Ompi and Novartis, etc.
The global Biologic Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Johnson & Johnson
Roche
Schott
Bayer
Nipro
Ompi
Novartis
Global Biologic Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Injectors market, Segment by Type:
Disposable Biologic Injectors
Reusable Biologic Injectors
Global Biologic Injectors market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biologic Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biologic Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
The global Biologic Injectors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Injectors in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgical Centers and Others, are propelling Biologic Injectors market. Disposable Biologic Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reusable Biologic Injectors segment is estimated at % CAGR for the next seven-year period.
Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Injectors covered in this report include BD, Johnson & Johnson, Roche, Schott, Bayer, Nipro, Ompi and Novartis, etc.
The global Biologic Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Johnson & Johnson
Roche
Schott
Bayer
Nipro
Ompi
Novartis
Global Biologic Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Injectors market, Segment by Type:
Disposable Biologic Injectors
Reusable Biologic Injectors
Global Biologic Injectors market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biologic Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biologic Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Biologic Injectors Market Overview
1.1 Biologic Injectors Product Overview
1.2 Biologic Injectors Market Segment by Type
1.2.1 Disposable Biologic Injectors
1.2.2 Reusable Biologic Injectors
1.3 Global Biologic Injectors Market Size by Type
1.3.1 Global Biologic Injectors Market Size Overview by Type (2018-2029)
1.3.2 Global Biologic Injectors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Biologic Injectors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biologic Injectors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Biologic Injectors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Biologic Injectors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Biologic Injectors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Biologic Injectors Sales Breakdown by Type (2018-2023)
2 Global Biologic Injectors Market Competition by Company
2.1 Global Top Players by Biologic Injectors Sales (2018-2023)
2.2 Global Top Players by Biologic Injectors Revenue (2018-2023)
2.3 Global Top Players by Biologic Injectors Price (2018-2023)
2.4 Global Top Manufacturers Biologic Injectors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biologic Injectors Market Competitive Situation and Trends
2.5.1 Biologic Injectors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Biologic Injectors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Injectors as of 2022)
2.7 Date of Key Manufacturers Enter into Biologic Injectors Market
2.8 Key Manufacturers Biologic Injectors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biologic Injectors Status and Outlook by Region
3.1 Global Biologic Injectors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Biologic Injectors Historic Market Size by Region
3.2.1 Global Biologic Injectors Sales in Volume by Region (2018-2023)
3.2.2 Global Biologic Injectors Sales in Value by Region (2018-2023)
3.2.3 Global Biologic Injectors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Biologic Injectors Forecasted Market Size by Region
3.3.1 Global Biologic Injectors Sales in Volume by Region (2024-2029)
3.3.2 Global Biologic Injectors Sales in Value by Region (2024-2029)
3.3.3 Global Biologic Injectors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Biologic Injectors by Application
4.1 Biologic Injectors Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.1.4 Others
4.2 Global Biologic Injectors Market Size by Application
4.2.1 Global Biologic Injectors Market Size Overview by Application (2018-2029)
4.2.2 Global Biologic Injectors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Biologic Injectors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biologic Injectors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Biologic Injectors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Biologic Injectors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Biologic Injectors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Biologic Injectors Sales Breakdown by Application (2018-2023)
5 North America Biologic Injectors by Country
5.1 North America Biologic Injectors Historic Market Size by Country
5.1.1 North America Biologic Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Biologic Injectors Sales in Volume by Country (2018-2023)
5.1.3 North America Biologic Injectors Sales in Value by Country (2018-2023)
5.2 North America Biologic Injectors Forecasted Market Size by Country
5.2.1 North America Biologic Injectors Sales in Volume by Country (2024-2029)
5.2.2 North America Biologic Injectors Sales in Value by Country (2024-2029)
6 Europe Biologic Injectors by Country
6.1 Europe Biologic Injectors Historic Market Size by Country
6.1.1 Europe Biologic Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Biologic Injectors Sales in Volume by Country (2018-2023)
6.1.3 Europe Biologic Injectors Sales in Value by Country (2018-2023)
6.2 Europe Biologic Injectors Forecasted Market Size by Country
6.2.1 Europe Biologic Injectors Sales in Volume by Country (2024-2029)
6.2.2 Europe Biologic Injectors Sales in Value by Country (2024-2029)
7 Asia-Pacific Biologic Injectors by Region
7.1 Asia-Pacific Biologic Injectors Historic Market Size by Region
7.1.1 Asia-Pacific Biologic Injectors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Biologic Injectors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Biologic Injectors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Biologic Injectors Forecasted Market Size by Region
7.2.1 Asia-Pacific Biologic Injectors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Biologic Injectors Sales in Value by Region (2024-2029)
8 Latin America Biologic Injectors by Country
8.1 Latin America Biologic Injectors Historic Market Size by Country
8.1.1 Latin America Biologic Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Biologic Injectors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Biologic Injectors Sales in Value by Country (2018-2023)
8.2 Latin America Biologic Injectors Forecasted Market Size by Country
8.2.1 Latin America Biologic Injectors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Biologic Injectors Sales in Value by Country (2024-2029)
9 Middle East and Africa Biologic Injectors by Country
9.1 Middle East and Africa Biologic Injectors Historic Market Size by Country
9.1.1 Middle East and Africa Biologic Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Biologic Injectors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Biologic Injectors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Biologic Injectors Forecasted Market Size by Country
9.2.1 Middle East and Africa Biologic Injectors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Biologic Injectors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BD
10.1.1 BD Company Information
10.1.2 BD Introduction and Business Overview
10.1.3 BD Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BD Biologic Injectors Products Offered
10.1.5 BD Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Biologic Injectors Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Biologic Injectors Products Offered
10.3.5 Roche Recent Development
10.4 Schott
10.4.1 Schott Company Information
10.4.2 Schott Introduction and Business Overview
10.4.3 Schott Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Schott Biologic Injectors Products Offered
10.4.5 Schott Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Biologic Injectors Products Offered
10.5.5 Bayer Recent Development
10.6 Nipro
10.6.1 Nipro Company Information
10.6.2 Nipro Introduction and Business Overview
10.6.3 Nipro Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nipro Biologic Injectors Products Offered
10.6.5 Nipro Recent Development
10.7 Ompi
10.7.1 Ompi Company Information
10.7.2 Ompi Introduction and Business Overview
10.7.3 Ompi Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ompi Biologic Injectors Products Offered
10.7.5 Ompi Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Biologic Injectors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novartis Biologic Injectors Products Offered
10.8.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biologic Injectors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biologic Injectors Industrial Chain Analysis
11.4 Biologic Injectors Market Dynamics
11.4.1 Biologic Injectors Industry Trends
11.4.2 Biologic Injectors Market Drivers
11.4.3 Biologic Injectors Market Challenges
11.4.4 Biologic Injectors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biologic Injectors Distributors
12.3 Biologic Injectors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
